首站-论文投稿智能助手
典型文献
Risk Factors for Severity and Mortality in Adult Patients Confirmed with COVID-19 in Sierra Leone: A Retrospective Study
文献摘要:
Background::The coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease. There is no recommended antiviral treatment approved for COVID-19 in Sierra Leone, and supportive care and protection of vital organ function are performed for the patients. This study summarized the clinical characteristics, drug treatments, and risk factors for the severity and prognosis of COVID-19 in Sierra Leone to provide evidence for the treatment of COVID-19.Methods::Data of 180 adult COVID-19 patients from the 34th Military Hospital in Freetown Sierra Leone between March 31, 2020 and August 11, 2020 were retrospectively collected. Patients with severe and critically ill are classified in the severe group, while patients that presented asymptomatic, mild, and moderate disease were grouped in the non-severe group. The clinical and laboratory information was retrospectively collected to assess the risk factors and treatment strategies for severe COVID-19. Demographic information, travel history, clinical symptoms and signs, laboratory detection results, chest examination findings, therapeutics, and clinical outcomes were collected from each case file. Multivariate logistic analysis was adopted to identify the risk factors for deaths. Additionally, the clinical efficacy of dexamethasone treatment was investigated.Results::Seventy-six (42.22%) cases were confirmed with severe COVID-19, while 104 patients (57.78%) were divided into the non-severe group. Fever (56.67%, 102/180) and cough (50.00%, 90/180) were the common symptoms of COVID-19. The death rate was 18.89% (34/180), and severe pneumonia (44.12%, 15/34) and septic shock (23.53%, 8/34) represented the leading reasons for deaths. The older age population, a combination of hypertension and diabetes, the presence of pneumonia, and high levels of inflammatory markers were significantly associated with severity of COVID-19 development ( P < 0.05 for all). Altered level of consciousness [odds ratio (OR)=56.574, 95% confidence interval (CI) 5.645-566.940, P=0.001], high levels of neutrophils (OR=1.341, 95%CI 1.109-1.621, P=0.002) and C-reactive protein (CRP) (OR=1.014, 95%CI 1.003-1.025, P=0.016) might be indicators for COVID-19 deaths. Dexamethasone treatment could reduce mortality [30.36% (17/56) vs. 50.00% (10/20)] among severe COVID-19 cases, but the results were not statistically significant ( P > 0.05). Conclusions::The development and prognosis of COVID-19 may be significantly correlated with consciousness status, and the levels of neutrophils and CRP.
文献关键词:
COVID-19;Clinical type;Dexamethasone;Risk factor
作者姓名:
Tu Bo;Lakoh Sulaiman;Xu Biao;Lado Marta;Cole Reginald;Chu Fang;Hastings-Spaine Susan;Jalloh Mohamed Bole;Zheng Junjie;Chen Weiwei;Sevalie Stephen
作者机构:
Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China;College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone;Joint Medical Unit, Republic of Sierra Leone Armed Forces, 34 Military Hospital Wilberforce Freetown, Freetown, Sierra Leone;Partners In Health, Sierra Leone
引用格式:
[1]Tu Bo;Lakoh Sulaiman;Xu Biao;Lado Marta;Cole Reginald;Chu Fang;Hastings-Spaine Susan;Jalloh Mohamed Bole;Zheng Junjie;Chen Weiwei;Sevalie Stephen-.Risk Factors for Severity and Mortality in Adult Patients Confirmed with COVID-19 in Sierra Leone: A Retrospective Study)[J].感染性疾病和免疫(英文),2022(02):83-92
A类:
Sierra,Leone,34th,Freetown
B类:
Risk,Factors,Severity,Mortality,Adult,Patients,Confirmed,Retrospective,Study,Background,coronavirus,disease,highly,infectious,respiratory,There,recommended,antiviral,approved,supportive,care,protection,vital,organ,function,performed,patients,This,study,summarized,clinical,characteristics,drug,treatments,risk,factors,severity,prognosis,provide,evidence,Methods,Data,adult,from,Military,Hospital,between,March,August,were,retrospectively,collected,severe,critically,ill,classified,while,that,asymptomatic,mild,moderate,grouped,laboratory,information,was,assess,strategies,Demographic,travel,history,symptoms,signs,detection,results,chest,examination,findings,therapeutics,outcomes,each,file,Multivariate,logistic,analysis,adopted,identify,deaths,Additionally,efficacy,dexamethasone,investigated,Results,Seventy,six,cases,confirmed,divided,into,Fever,cough,common,pneumonia,septic,shock,represented,leading,reasons,older,age,population,combination,hypertension,diabetes,presence,levels,inflammatory,markers,significantly,associated,development,Altered,consciousness,odds,ratio,confidence,interval,neutrophils,reactive,protein,might,indicators,Dexamethasone,could,reduce,mortality,among,but,not,statistically,Conclusions,may,correlated,status,Clinical,type
AB值:
0.518634
相似文献
A Case Series of Olfactory Dysfunction in Imported COVID-19 Patients: A 12-Month Follow-Up Study
WANG Ni;YANG Ming Bo;YANG Pu Ye;CHEN Ren Bo;HUANG Fei;SHI Nan Nan;MA Yan;ZHANG Yan;XU You;LIU Si Hong;LU Heng Yi;FU Qing Qing;FAN Yi Pin;KAN Hong Min;WANG Xiao Hong;GUO Ya Ling-National Center for Tuberculosis Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206,China;Hepatology Department of TCM,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Integrated Chinese and Western Medicine,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Infection,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700, China
Hypertension Exacerbates Severity and Outcomes of CO VID-19 in Elderly Patients:A Retrospective Observational Study
Li-song DAI;Meng-pei ZHU;Yu-min LI;Hong-mei ZHOU;Hong-li LIAO;Pan-pan CHENG;Xin-yue XIA;Xue-yun YAO;Hui-juan ZHANG;Xiao-qi LIU;Wei HUANG;Lei WAN;Xiang-yang XU;Fu-rong WANG;Cheng-qi XU-Department of Radiology,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430070,China;Department of Respiratory,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430070,China;Department of Radiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430015,China;Department of Radiology,Wuhan Eighth Hospital,Wuhan 430014,China;Department of Cardiology,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430070,China;Department of Ultrasound,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430070,China;Key Laboratory of Molecular Biophysics of the Ministry of Education,Cardio-X Institute,College of Life Science and Technology and Center for Human Genome Research,Huazhong University of Science and Technology,Wuhan 430070,China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study
Li Jielin;Hu Jiexuan;Li Peng;Wu Yongdong;Wang Yongjun;Ji Ming;Hua Haiyang;Ran Wenbin;Pan Yanglin;Zhang Shutian-Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China;Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Department of Gastroenterology, Cheng De Central Hospital, Chengde, Hebei 067000, China;Department of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu, Sichuan 610031, China;Xijing Hospital of Digestive Diseases, Air Force Medical University of People’s Liberation Army, Xi’an, Shaanxi 710032, China
The predictors of long-COVID in the cohort of Turkish Thoracic Society-TURCOVID multicenter registry: One year follow-up results
Serap Argun Baris;Oya Baydar Toprak;Pelin Duru Cetinkaya;Fusun Fakili;Nurdan Kokturk;Seval Kul;Ozgecan Kayalar;Yildiz Tutuncu;Emel Azak;Mutlu Kuluozturk;Pinar Aysert Yildiz;Pelin Pinar Deniz;Oguz Kilinc;Ilknur Basyigit;Hasim Boyaci;Ismail Hanta;Neslihan Kose;Gulseren Sagcan;Caglar Cuhadaroglu;Hacer Kuzu Okur;Hasan Selcuk Ozger;Begum Ergan;Mehtap Hafizoglu;Abdullah Sayiner;Esra Nurlu Temel;Onder Ozturk;Tansu Ulukavak Ciftci;Ipek Kivilcim Oguzulgen;Vildan Avkan Oguz;Firat Bayraktar;Ozlem Ataoglu;Merve Ercelik;Pinar Yildiz Gulhan;Aysegul Tomruk Erdem;Muge Meltem Tor;Oya Itil;Hasan Bayram-Department of Pulmonary Medicine,Faculty of Medicine,Kocaeli University,Kocaeli,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Cukurova University,Adana,Turkey;Department of Pulmonary Medicine,University of Health Sciences,Adana City Training and Research Hospital,Adana,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Biostatistics,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey;Department of Immunology,Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Kocaeli University,Kocaeli Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Firat University,Elazig,Turkey;Department of Infectious Diseases and Clinical Microbiology,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Pulmonary Medicine,Bilecik Training and Research Hospital,Bilecik,Turkey;Department of Pulmonary Medicine,Altunizade Acibadem Hospital,Istanbul,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Ege University,Izmir,Turkey;Department of Infectious Diseases and Clinical Microbiology,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Internal Medicine,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Duzce University,Duzce,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Zonguldak Bulent Ecevit University,Zonguldak,Turkey;Department of Pulmonary Medicine,Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey
Global prevalence, mortality, and main risk factors for COVID-19 associated pneumocystosis: A systematic review and meta-analysis
Hossein Khodadadi;Ehsan Ahmadpour;Sanam Nami;Rasoul Mohammadi;Hanieh Hosseini;Mahsa Behravan;Hamid Morovati-Department of Parasitology and Mycology,School of Medicine,Shiraz University of Medical Sciences,Shiraz,Iran;Drug Applied Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Mycology and Parasitology,School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Parasitology and Mycology,School of Medicine,Isfahan University of Medical Sciences,Isfahan,Iran;Immunology Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Student Research Committee,Shiraz University of Medical Sciences,Shiraz,Iran
Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China ☆
Bai Zhenjiang;Li Qing;Chen Qinghui;Niu Changming;Wei Yu;Huang Hanpeng;Zhao Wei;Chen Nian;Yao Xin;Zhang Qiang;Mu Chuanyong;Feng Jian;Zhu Chuanlong;Li Zhuo;Ding Ming;Feng Binhui;Jin Chaochao;Lu Xiang;Yang Yi;Wu Shuiyan;Shu Xiaochen;Hu Lifang;Qiu Haibo;Huang YingZi-Pediatric Intensive Care Unit, Children’s Hospital of Soochow University, Suzhou, Jiangsu 215025, China;Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;Department of Infectious Diseases, Children’s Hospital of Soochow University, Suzhou, Jiangsu 215025, China;Department of Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210011, China;Department of Respirology, Jiangsu Province Hospital of TCM, Nanjing, Jiangsu 210046, China;Department of Respirology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China;Department of Critical Care Medicine, Sir Run Hospital Nanjing Medical University, Nanjing, Jiangsu 211112, China;Department of Infectious Diseases, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211103, China;Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211103, China;Department of Respirology, Southeast University Zhongda Hospital, Nanjing, Jiangsu 210009, China;Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China;Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226019, China;Department of Emergency, Children’s Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, China;Department of Critical Care Medicine, Huangshi Central Hospital, Huangshi, Hubei 435002, China;Department of Oncology, Huangshi Hospital of TCM (Infectious Disease Hospital, Huangshi, Hubei 435002, China;Department of Geriatric Medicine, Sir Run Hospital Nanjing Medical University, Nanjing, Jiangsu 211112, China;Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215031, China;Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215031, China
A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province,China
Jiaojiao Xie;Ding Shi;Mingyang Bao;Xiaoyi Hu;Wenrui Wu;Jifang Sheng;Kaijin Xu;Qing Wang;Jingjing Wu;Kaicen Wang;Daiqiong Fang;Yating Li;Lanjuan Li-State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;State Key Laboratory of Genetic Engineering,Institute of Biostatistics,School of Life Sciences,Fudan University,Shanghai 200433,China;Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,Key Lab of Combined Multi-organ Transplantation of the Ministry of Health,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;Division of of Endocrinology and Metabolism,Department of Internal Medicine System,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China
Factors Predicting Progression to Severe COVID-19:A Competing Risk Survival Analysis of 1753 Patients in Community Isolation in Wuhan,China
Simiao Chen;Hui Sun;Mei Heng;Xunliang Tong;Pascal Geldsetzer;Zhuoran Wang;Peixin Wu;Juntao Yang;Yu Hu;Chen Wang;Till B?rnighausen-Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China;Heidelberg Institute of Global Health(HIGH),Faculty of Medicine and University Hospital,Heidelberg University,Heidelberg 69120,Germany;Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Pulmonary and Critical Care Medicine,Beijing Hospital,Beijing 100730,China;National Center of Gerontology,Institute of Geriatric Medicine,Beijing 100730,China;Division of Primary Care and Population Health,Department of Medicine,Stanford University,Stanford,CA 94305,USA;Peking Union Medical College Hospital,Beijing 100730,China;State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China;National Clinical Research Center for Respiratory Diseases,Beijing 100029,China;Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。